From Research to Practice
Postgraduate Training Course in Reproductive Health/Chronic Disease
Geneva 2004
23 February – 2 April 2004
organised by
the Geneva Foundation for Medical Education
and Research,
the International Association for Maternal and Neonatal Health (IAMANEH)
the UNDP/UNFPA/WHO/World Bank Special Programme for Research in Human Reproduction,
Department of Reproductive Health and Research; Family and Community Health
Cluster (WHO/RHR)
the WHO Noncommunicable Diseases and Mental Health Cluster (WHO/NMH)
and
Policy and Strategy on Traditional Medicine/Department of Essential Drugs
and Medicines Policy and Department of Essential Health Technologies; Health
Technology and Pharmaceuticals Cluster (WHO/HTP)
in collaboration with
the Department of Health of the Canton of Geneva
the Faculty of Medicine, Geneva University
and
the Geneva Medical Association
Opening
ceremony - Images
Course
files
List of lecturers
List of participants : Chronic disease
List of participants : Reproductive health
Dinner of March 24
Scientific reviews presented by the
participants - Oral presentations
LECTURE PLAN
Common course: Research methodology at WHO/Salle B
The opening ceremony on 23 February will be held in the Executive Board Room, WHO
Date | AM | Topic | Speaker | PM | Topic | Speaker |
February 23 | 09.00 | Organisational matters | Organisers; venue: GFMER | 13.00 | Opening ceremony | J Villar C Tukuitonga A Campana PF Unger J Philippe B Bourrit X Zhang |
15.30 | Welcome cocktail | WHO/ Restaurant | ||||
February 24 | 09.00 | The gap between evidence and practice in NCDs | C Tukuitonga | 14.00 | Visit of the WHO library |
|
10.15 | The gap between evidence and practice in Reproductive Health | J Villar | ||||
February 25 | 09.00 | Types of epidemiological studies | J Villar | 14.00 | Visit of the CMU library/computer rooms, Internet and Medline | A Campana |
10.15 | Cohort studies | H Wolff | ||||
11.15 | Case-control studies | H Wolff | ||||
February 26 | 09.00 | Randomized controlled trials | M Merialdi | 14.00 | Introduction to Excel, Word and Powerpoint | S Koppenhoefer |
10.15 | Community interventions and equivalence trials | G Piaggio | 14.30 | Computer basics | S Koppenhoefer | |
February 27 | 09.00 | Methodological issues in the measurement of maternal mortality and morbidity | A Betran | 14.00 | Methodological issues in the measures of mental disorders | M van Ommeren |
10.15 | Methodological issues in the measurement of chronic disease | N Unwin | ||||
11.15 | Methodological issues in the use of anthropometry for evaluation of nutritional status | M Bloessner | ||||
March 01 | 09.00 | Screening for obstetrics and intrapartum events | M Merialdi | |||
10.15 | Ethical issues in research | E Vayena | ||||
March 02 | 09.00 | Research synthesis, including meta-analysis | M Gülmezoglu | 14.00 | How to write a scientific paper | J Khanna |
10.15 | The Cochrane Collaboration | R Kulier | ||||
11.15 | Systematic reviews of observational data | A Betran | ||||
March 03 | 09.00 - 10.30 | Strategies for data analysis : cohort & case control studies | I Malonza | 14.00 | Screening for chronic disorder | K Strong |
10.45 - 12.00 |
Strategies for data analysis : RCT & community interventions | G Piaggio | ||||
March 04 | 09.00 | Introduction to health economics | J Chen | 14.00 | Gender, Women's Health, Human Rights | E Kismodi |
10.15 | Critical appraisal of research reports | L Say | ||||
March 05 | 09.00 | The WHO Reproductive Health Library | A Shah | |||
10.15 | Data analysis : summary | J Villar |
Course 1 : Reproductive Health at WHO/room M505
Lectures on March 10 will be held at the Faculty of Medicine (CMU), Geneva
Date | AM | Topic | Speaker | PM | Topic | Speaker |
March 08 | 09.00 | Fertilisation/Implantation | G Bianchi | 14.00 | From Reproductive Health to Contraception | G Benagiano |
10.00 | The HPG axis | R Gaillard | ||||
11.00 | Puberty | V Schwitzgebel | ||||
12.00 | The menstrual cycle | F Pralong | ||||
March 09 | 09.00 | Polycystic ovary syndrome | F Pralong | 14.00 | Diabetes and Reproduction | J Philippe |
10.00 | Endometriosis | D Chardonnens | ||||
11.00 | Oral contraception and the HPG axis | F Pralong | ||||
12.00 | Estrogen (ER) receptor biology: Implications for HRT? | C Meier | ||||
March 10 | 09.00 | Introduction / Genetic consultation in OBGYN | M Gersbach | 14.00 | Clinical pre - and postnatal cytogenetics | S Gagos |
10.00 | Genetic counselling: principles, practice, ethics | M Gersbach | ||||
11.00 | Principles of molecular diagnosis | M Morris | 15.00 | The human genome project, its implication for the practice of medicine in the 21st century | S Antonarakis | |
March 11 | 09.00 | Reproductive health research at WHO | P v Look | |||
10.00 | Long-acting hormonal contraceptive methods | J Schmidt | ||||
11.00 | Combined oral contraceptives | E Ezcurra | ||||
March 12 | 09.00 | Preventing unsafe abortion | R Kulier | |||
10.00 | Future methods of fertility regulation | C d'Arcangues | ||||
11.00 | Emergency contraception | H von Hertzen | ||||
March 15 | 09.00 | Female sterilization | HB Peterson | |||
10.00 | Medical eligibility criteria for contraceptives | HB Peterson | ||||
March 16 | 09.00 | Investigation of the infertile couple | A Campana | |||
10.00 | Treatment of infertility | A Campana | ||||
11.00 | Treatment of infertility | A Campana | ||||
12.00 | Surgical treatment of male infertility | G de Boccard | ||||
March 17 | 09.00 | Osteoporosis | R Rizzoli | |||
10.00 | Assisted reproductive technologies | H Lucas | ||||
11.00 | Ethical issues in assisted reproductive technologies | E Vayena | ||||
12.00 | Menstrual cycle disorders | D Chardonnens | ||||
March 18 | 09.00 | Recurrent miscarriage | A Campana | 14.00 | Laparoscopy in developing countries | P Meyer |
10.00 | Menopause | G Bianchi | ||||
11.00 | Hormone replacement therapy | G Bianchi | ||||
March 19 | 09.00 | Designing and evaluating clinical algorithms for STI case management | F Ndowa / S Dludlu |
|||
10.00 | HIV infection in pregnancy | F Ndowa | ||||
11.00 | STIs and bacterial vaginosis in pregnancy | F Ndowa / F Hawkes |
||||
March 22 | 09.00 | Dual protection: prevention of STIs/HIV and pregnancy | K O'Reilly | |||
11.00 | Cervical cancer: screening and detection | P Vassilakos | ||||
12.00 | Colposcopy | E Mégevand | ||||
March 23 | 09.00 | HPV infection in gynaecology: prophylactic and therapeutic vaccines | P-Y Dietrich | |||
11.00 | Breast Cancer: diagnosis and treatment | G Vlastos | ||||
12.00 | Palliative care | N Steiner | ||||
March 24 | 08.30 | Introduction to the obstetrics module | J Villar | |||
09.00 | Prenatal diagnosis | Ph Extermann | ||||
10.00 | Ultrasound in obstetrics | Ph Extermann | ||||
11.00 | Evidence Based Antenatal Care | J Villar | ||||
12.00 | Impaired fetal growth | M Merialdi | ||||
March 25 | 09.00 | Treatment of hypertension in pregnancy | L Say | 14.00 | Making pregnancy safer | R Kabra |
10.00 | Nutritional interventions during pregnancy for the prevention of maternal morbidity, mortality and preterm delivery | M Merialdi | ||||
11.00 | Cesarean section in the world - A critical appraisal | JG Cecatti | ||||
12.00 | Obstetric anaesthesia and analgesia | M Cherian | ||||
March 26 | 09.00 | Neonatal resuscitation | D Woods | |||
10.00 | Prevention and treatment of postpartum haemorrhage | M Gülmezoglu | ||||
11.00 | Postpartum infection | N Nik | ||||
12.00 | Obstetrical vaginal fistula: surgical approach | C-H Rochat | ||||
March 29, 30, April 01 | Exams |
Course 2 : Chronic Disease at WHO/room M605
Date | AM | Topic | Speaker | PM | Topic | Speaker |
March 08 | 09.30 | A Global Approach: Addressing the leading causes of death and disability | C Le Galés-Camus | |||
10.15 | Responding to the burden of NCDs | R Beaglehole | ||||
11.15 | Developing research protocols and proposals: open session for students | C Tukuitonga / A Kalache | ||||
March 09 | 09.00 | Global burden of disease-data, methods, results overview | C Mathers | |||
10.15 | Comparative risk assessment for NCDs | K Strong / C Mathers |
||||
11.15 | Epidemiological approaches to measurement of risk | K Sibuya | ||||
March 10 | 09.00 | Surveillance - Introduction and STEPS | R Bonita / T Armstrong |
|||
10.15 | Surveillance - InfoBase | R Bonita / K Strong |
||||
11.15 | Surveillance-Global Youth Health Surveys | L Riley | ||||
March 11 | 09.00 | Data sources / Existing data sources for NCDs | K Strong | |||
10.15 | Global strategy on diet, physical activity and health | A Waxman | ||||
11.15 | Schools setting for NCD prevention? | C Gollmar | ||||
March 12 | 09.00 | Primary Prevention of NCDs | C Tukuitonga | |||
10.15 | Managing behavioral risks | J Epping-Jordan | ||||
11.15 | Primary prevention: physical activity | T Armstrong | ||||
March 15 | 09.00 | Mental Health & substance abuse | J Bertolote | |||
10.15 | Mental Health & substance abuse | J Bertolote | ||||
11.15 | Mental Health & substance abuse | J Bertolote | ||||
March 16 | 09.00 |
Evidence-based approaches
to the prevention of CVDs Cost Effective Cardiovascular Interventions for low and middle income countries |
S Mendis | |||
10.15 | CVD risk assessment & management
with hypertension as the entry point 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension |
S Mendis | ||||
11.15 | Primary and secondary prevention
of myocardial infarction, stroke and rheumatic heart disease Prevention of Recurrent Heart Attacks and Strokes in Low and Middle Income Populations |
S Mendis | ||||
March 17 | 09.00 | Secondary prevention: screening (breast cancer) | A Ullrich | |||
10.15 | Primary prevention: Tobacco | C Audera | ||||
11.15 | Primary prevention: FCTC | W Onizivu / G Vestal | ||||
March 18 | 09.00 | Stroke | T Truelsen | |||
10.15 | Stroke | T Truelsen | ||||
11.15 | Stroke | T Truelsen | ||||
March 19 | 09.00 | The global burden of diabetes | N Unwin | |||
10.15 | The prevention of diabetes and its complications | N Unwin | ||||
11.15 | Diabetes Action Now - A joint World Health Organization (WHO) - International Diabetes Federation (IDF) Programme | N Unwin | ||||
March 22 | 09.00 | Chronic diseases and risks: the long-term view | C Hawkes | |||
10.15 | Integrated NCD prevention | R Shao | ||||
11.15 | HP effectiveness | KC Tang | ||||
March 23 | 09.00 | NCCP working groups | A Ullrich | |||
10.15 | NCCP working groups | A Ullrich | ||||
11.15 | NCCP working groups | A Ullrich | ||||
March 24 | 09.00 | NCD risks: a lifecourse perspective | A Kalache | |||
10.15 | Ageing and NCDs | A Kalache | ||||
11.15 | Ageing and NCDs | A Kalache | ||||
March 25 | 09.00 | Primary prevention: Alcohol | L Riley | |||
10.15 | Alcohol and drugs | I Obot | ||||
11.15 | Primary prevention: Nutrition and diet | C Nishida | ||||
March 26 | 09.00 | Improving health care for chronic conditions | J Epping-Jordan | |||
10.15 | Improving health care for chronic conditions | J Epping - Jordan | ||||
March 29 | 09.00 | Violence and injuries | D Meddings | |||
10.15 | Violence and injuries | D Meddings | ||||
11.15 | Violence and injuries | D Meddings | ||||
March 30 | 09.00 - 12.00 | Exams | C Tukuitonga | |||
March 31, April 01 | 09.00 - 12.00 | Review | All | |||
April 02 | 09.00 - 12.00 | Presentations | All |